AHA Urges the CMS to Consider Alternative Payment Solutions for CAR T Therapy

AHA writes to urge the Centers for Medicare & Medicaid Services to consider alternative payment solutions for Chimeric Antigen Receptor T-cell (CAR T) therapy.

View full details in the following letter. 

Related Resources

Presentation Resource
Member
Advancing Health Podcast
Public
On this AHA Advancing Health Podcast, author Safi Bahcall
Presentation Resource
Member
Advisory
Member
On Aug. 2, the Centers for Medicare…
Advisory
Member
The Centers for Medicare…
Advisory
Member
On July 31, the Centers for Medicare…